Results of a randomized phase 3 study of oral sapacitabine in elderly patients with newly diagnosed acute myeloid leukemia (SEAMLESS)
Journal article published in 2021 by
Hagop M. Kantarjian 
,
Kebede H. Begna ,
Jessica K. Altman,
Stuart L. Goldberg ,
Mikkael A. Sekeres ,
Stephen A. Strickland ,
Martha L. Arellano ,
David F. Claxton ,
Maria R. Baer ,
Marc Gautier,
Ellin Berman ,
Karen Seiter ,
Scott R. Solomon ,
Gary J. Schiller ,
Selina M. Luger
and other authors.
,
Kebede H. Begna ,
Jessica K. Altman,
Stuart L. Goldberg ,
Mikkael A. Sekeres ,
Stephen A. Strickland ,
Martha L. Arellano ,
David F. Claxton ,
Maria R. Baer ,
Marc Gautier,
Ellin Berman ,
Karen Seiter ,
Scott R. Solomon ,
Gary J. Schiller ,
Selina M. Luger
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 